Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?-Reference-Cited by-同舟云学术

Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?

Published:2017-04-12 Issue:8 Volume:19 Page:974-986
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Ferreira João Pedro¹²,Mentz Robert J.³,Pizard Anne¹,Pitt Bertram⁴,Zannad Faiez¹

Affiliation:

1. Centre d'Investigation Clinique Plurithématique 1433, INSERM U1116; University of Lorraine; Nancy France

2. Department of Physiology and Cardiothoracic Surgery; Cardiovascular Research and Development Unit, Faculty of Medicine, University of Porto; Porto Portugal

3. Duke Clinical Research Institute and Division of Cardiology, Department of Medicine; Duke University Medical Center; Durham NC USA

4. Department of Cardiology; University of Michigan School of Medicine; Ann Arbor MI USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference67 articles.

1. The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology;Kirchhof;Eur Heart J,2014

2. Risk-guided therapy: a first step to personalized medicine;Zannad;Eur J Prev Cardiol,2012

3. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission;Kasper;J Am Coll Cardiol,2002

4. Post-hoc data analysis: benefits and limitations;Curran-Everett;Curr Opin Allergy Clin Immunol,2013

5. Efficiencies of platform clinical trials: a vision of the future;Saville;Clin Trials,2016

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individualized Treatment Effect Prediction with Machine Learning — Salient Considerations;NEJM Evidence;2024-03-26

2. Rationale, Design, and Patient Characteristics of a Cluster-Randomized Pragmatic Trial to Improve Mineralocorticoid Antagonist Use;JACC: Heart Failure;2024-02

3. Effect of eplerenone on clinical stability of Japanese patients with acute heart failure;International Journal of Cardiology;2023-03

4. Steroidal MRA Across the Spectrum of Renal Function;JACC: Heart Failure;2022-11

5. Increased Soluble Epoxide Hydrolase Activity Positively Correlates with Mortality in Heart Failure Patients with Preserved Ejection Fraction: Evidence from Metabolomics;Phenomics;2022-10-27